A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

NCT00191919 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

310

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Duloxetine Hydrochloride
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]